C. Assaid

803 total citations
4 papers, 464 citations indexed

About

C. Assaid is a scholar working on Physiology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, C. Assaid has authored 4 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Physiology, 1 paper in Pathology and Forensic Medicine and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in C. Assaid's work include Neurological disorders and treatments (1 paper), Voice and Speech Disorders (1 paper) and Parkinson's Disease Mechanisms and Treatments (1 paper). C. Assaid is often cited by papers focused on Neurological disorders and treatments (1 paper), Voice and Speech Disorders (1 paper) and Parkinson's Disease Mechanisms and Treatments (1 paper). C. Assaid collaborates with scholars based in United States, Belgium and United Kingdom. C. Assaid's co-authors include Christopher J. Jones, Christine Furtek, Alan M. Rapoport, Xiaoyin Fan, Christopher R. Lines, Tony W. Ho, Tiffany Woo, G Shepherd, Mark Leibowitz and Aaron Ellenbogen and has published in prestigious journals such as Neurology, British Journal of Anaesthesia and The Journal of Clinical Pharmacology.

In The Last Decade

C. Assaid

4 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Assaid United States	3	342	228	149	113	53	4	464
Astrid Bergerot United Kingdom	8	229 0.7×	170 0.7×	137 0.9×	102 0.9×	64 1.2×	9	379
Steven Sweeney Netherlands	7	308 0.9×	201 0.9×	169 1.1×	74 0.7×	31 0.6×	7	438
Anne Luise Haulund Vollesen Denmark	13	590 1.7×	316 1.4×	222 1.5×	180 1.6×	93 1.8×	15	634
Kayi Y. Chan Netherlands	13	405 1.2×	217 1.0×	144 1.0×	145 1.3×	71 1.3×	22	544
Michele Feleppa Italy	11	324 0.9×	144 0.6×	138 0.9×	54 0.5×	50 0.9×	18	493
Tim Kelderman Belgium	4	263 0.8×	152 0.7×	109 0.7×	67 0.6×	39 0.7×	5	322
Denise E. Chou United States	12	461 1.3×	271 1.2×	200 1.3×	23 0.2×	37 0.7×	28	713
J. Németh Hungary	8	191 0.6×	125 0.5×	217 1.5×	168 1.5×	61 1.2×	9	510
Kimberly D. Mackenzie United States	13	191 0.6×	68 0.3×	118 0.8×	140 1.2×	44 0.8×	19	462
Goldstein Dj United States	10	340 1.0×	211 0.9×	253 1.7×	92 0.8×	79 1.5×	19	597

Countries citing papers authored by C. Assaid

Since Specialization

Citations

This map shows the geographic impact of C. Assaid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Assaid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Assaid more than expected).

Fields of papers citing papers by C. Assaid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Assaid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Assaid. The network helps show where C. Assaid may publish in the future.

Co-authorship network of co-authors of C. Assaid

This figure shows the co-authorship network connecting the top 25 collaborators of C. Assaid. A scholar is included among the top collaborators of C. Assaid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Assaid. C. Assaid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Muccino, David, AH Morice, Surinder S. Birring, et al.. (2019). Rationale and Design of Two, Phase 3, Randomized Controlled Trials (COUGH-1 and COUGH-2) of Gefapixant, A P2x3 Receptor Antagonist, in Refractory and Unexplained Chronic Cough. A4700–A4700. 1 indexed citations

2.

Schulz, Valerie, Tiffany Woo, C. Assaid, et al.. (2018). Hypersensitivity incidence after sugammadex administration in healthy subjects: a randomised controlled trial. British Journal of Anaesthesia. 121(4). 749–757. 45 indexed citations

3.

Addy, Carol, C. Assaid, David Hreniuk, et al.. (2009). Single‐Dose Administration of MK‐0657, an NR2B‐Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease. The Journal of Clinical Pharmacology. 49(7). 856–864. 51 indexed citations

4.

Ho, Tony W., Xiaoyin Fan, C. Assaid, et al.. (2007). Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology. 70(16). 1304–1312. 367 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact